4a-O-Benzyloxy (3S,4S)-Ezetimibe is a chemical compound that belongs to the class of cholesterol absorption inhibitors, primarily used in the management of hyperlipidemia. This compound features a complex molecular structure characterized by a benzyloxy group, which enhances its lipophilicity and bioavailability. The stereochemistry of the compound is significant, as it possesses specific chiral centers that contribute to its biological activity and efficacy. The compound's mechanism of action involves the selective inhibition of intestinal cholesterol absorption, leading to a reduction in serum cholesterol levels. It is typically administered in oral form and is often studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion. Safety and efficacy profiles are evaluated through clinical trials, and the compound is subject to regulatory scrutiny before approval for therapeutic use. Overall, 4a-O-Benzyloxy (3S,4S)-Ezetimibe represents a valuable tool in lipid management, with ongoing research exploring its potential benefits and applications in cardiovascular health.

4a€-O-Benzyloxy (3S,4S)-Ezetimibe

1683564-73-9: 4a-O-Benzyloxy (3S,4S)-Ezetimibe is a chemical compound that belongs to the class of cholesterol absorption inhibitors, primarily used in the management of hyperlipidemia. This compound features a complex molecular structure characterized by a benzyloxy group, which enhances its lipophilicity and bioavailability. The stereochemistry of the compound is significant, as it possesses specific chiral centers that contribute to its biological activity and efficacy. The compound's mechanism of action involves the selective inhibition of intestinal cholesterol absorption, leading to a reduction in serum cholesterol levels. It is typically administered in oral form and is often studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion. Safety and efficacy profiles are evaluated through clinical trials, and the compound is subject to regulatory scrutiny before approval for therapeutic use. Overall, 4a-O-Benzyloxy (3S,4S)-Ezetimibe represents a valuable tool in lipid management, with ongoing research exploring its potential benefits and applications in cardiovascular health.

CAS 1683564-73-9

4a€-O-Benzyloxy (3S,4S)-Ezetimibe

Ezetimibe Impurity 79

Ref: 4Z-E-06121

4'-O-Benzyloxy (3S,4S)-Ezetimibe

Ref: ST-EA-CP-E6142